Strides Pharma News: Read Latest News & Live Updates on Strides Pharma, Photos, Videos at CNBCTV18.com

homeStrides Pharma News

Strides Pharma NEWS

All

market | Apr 9, 2024 1:30 PM IST
Strides Pharma arm gets USFDA nod for major depressive disorder treatment drug
market | Apr 8, 2024 12:50 PM IST
Strides Pharma shares hit 52-week high despite USFDA inspection observations for Chennai facility
market | Dec 21, 2023 2:05 PM IST
Strides Pharma gains nearly 5% on securing ₹31 crore credit facility for its South Africa subsidiary
market | Nov 23, 2023 10:21 AM IST
Strides Pharma's Singapore subsidiary gets USFDA nod for oral solution to clear intestines
market | Nov 21, 2023 12:39 PM IST
Strides Pharma gains nearly 4% on USFDA approval for oral solution to treat seizures
market | Oct 30, 2023 12:41 PM IST
Strides Pharma sees Q2 net loss of ₹131 cr due to exceptional expenses; co on track to meet FY24 outlook
healthcare | Oct 4, 2023 5:10 PM IST
Strides Pharma receives USFDA approval for HIV medication
photos | Sept 26, 2023 6:58 AM IST
Stocks to Watch: ITC, Wipro, Strides Pharma, Sheela Foam, Welspun Corp and more
market | Sept 25, 2023 3:43 PM IST
Strides Pharma approves spinoff of CDMO, soft gelatin business; stock up 8%
healthcare | Sept 14, 2023 6:54 PM IST
Strides Pharma gets tentative USFDA approval for HIV drug dolutegravir
market | Sept 7, 2023 4:20 PM IST
Strides Pharma gains more than 5% to trade near 52-week high amid internal reorganisation
business | Aug 30, 2023 10:59 AM IST
Strides Pharma gets USFDA approval for Mycophenolate Mofetil oral suspension
market | Aug 2, 2023 4:10 PM IST
Here's why Strides Pharma shares fell 7% today
business | Aug 2, 2023 1:37 PM IST
Strides Pharma board approves merger of Vivimed Life with co; shares dip 5%
business | Aug 2, 2023 12:22 PM IST
Strides Pharma Q1 Results: Management says on track to achieve FY24 targets as losses narrow

Strides Pharma NEWS

Strides Pharma arm gets USFDA nod for major depressive disorder treatment drug

Strides Pharma shares hit 52-week high despite USFDA inspection observations for Chennai facility

Strides Pharma gains nearly 5% on securing ₹31 crore credit facility for its South Africa subsidiary

Strides Pharma's Singapore subsidiary gets USFDA nod for oral solution to clear intestines

Strides Pharma gains nearly 4% on USFDA approval for oral solution to treat seizures

Strides Pharma sees Q2 net loss of ₹131 cr due to exceptional expenses; co on track to meet FY24 outlook

Strides Pharma receives USFDA approval for HIV medication

Stocks to Watch: ITC, Wipro, Strides Pharma, Sheela Foam, Welspun Corp and more

Strides Pharma approves spinoff of CDMO, soft gelatin business; stock up 8%

Strides Pharma gets tentative USFDA approval for HIV drug dolutegravir

Strides Pharma gains more than 5% to trade near 52-week high amid internal reorganisation

Strides Pharma gets USFDA approval for Mycophenolate Mofetil oral suspension

Here's why Strides Pharma shares fell 7% today

Strides Pharma board approves merger of Vivimed Life with co; shares dip 5%

Strides Pharma Q1 Results: Management says on track to achieve FY24 targets as losses narrow